PCV01 is a peptide vaccine harvested from a tumour antigen complex. This is delivered by conjugation with a viral PCV-001 is a precision cancer vaccine that trains the immune system to recognise novel tumour associated antigens (TAA) on immunologically cold tumours. We are currently planning clinical studies to translate the cancer vaccine into human trials.